SPXA yields 20408.16% · PFE yields 6.13%● Live data
📍 SPXA pulled ahead of the other in Year 1
Combined, SPXA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPXA + PFE for your $10,000?
Spectrum DNA, Inc. operates a social media studio that creates digital networked applications, which are engines of engagement (enginets) primarily for media outlets and brand advertisers. Its enginets are branded Web and wireless-based network experiences, and Web and mobile applications. The company's principal enginets include The Addictionary, a social wordplay engine used as the foundation for apps created to engage in word-related apps; and PlanetTagger, a location-enabled integrated social marketing platform that offers online communities a tool, which centralize the social media marketing and editorial programming, as well as provides the community users with utility to extend the reach of the community. It also offers OptEngage, a new class configurable and contextual browser application that talks to a cloud-based platform, which enables clients to deliver content and utility to their users on the Web; and the Hucklemonkey, an application programming interface API that integrates gamification into clients existing services or new applications. The company was founded in 2006 and is based in Park City, Utah.
Full SPXA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.